Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 11, 2017
Previous Article Next Article

Antibiotics and specialized metabolites from the human microbiota

Author affiliations

Abstract

Covering: 2000 to 2017

Decades of research on human microbiota have revealed much of their taxonomic diversity and established their direct link to health and disease. However, the breadth of bioactive natural products secreted by our microbial partners remains unknown. Of particular interest are antibiotics produced by our microbiota to ward off invasive pathogens. Members of the human microbiota exclusively produce evolved small molecules with selective antimicrobial activity against human pathogens. Herein, we expand upon the current knowledge concerning antibiotics derived from human microbiota and their distribution across body sites. We analyze, using our in-house chem-bioinformatic tools and natural products database, the encoded antibiotic potential of the human microbiome. This compilation of information may create a foundation for the continued exploration of this intriguing resource of chemical diversity and expose challenges and future perspectives to accelerate the discovery rate of small molecules from the human microbiota.

Graphical abstract: Antibiotics and specialized metabolites from the human microbiota

Back to tab navigation

Supplementary files

Article information


Submitted
27 Mar 2017
First published
11 Oct 2017

Nat. Prod. Rep., 2017,34, 1302-1331
Article type
Review Article

Antibiotics and specialized metabolites from the human microbiota

W. K. Mousa, B. Athar, N. J. Merwin and N. A. Magarvey, Nat. Prod. Rep., 2017, 34, 1302
DOI: 10.1039/C7NP00021A

Social activity

Search articles by author

Spotlight

Advertisements